Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
|3rd August 2016
In this article, Consultant Jeremy Poland examines some of the key dynamics in prostate cancer multi-disciplinary teams across Europe and how the recent trends impact the opportunities available to healthcare marketers.
|19th July 2016
In the last 13 years, only one new drug has been approved for patients with Alzheimer's Disease. The most recently approved drug was in 2014, bringing the total number of agents approved across AD to 5. In this article, Consultant David Cooney explores the success rate of trials in AD and the reasons for this incredulous situation, as well as look at the some of the glimmers of light at the end of the tunnel.
|13th June 2016
In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities of Britain exiting the EU (Brexit).
|8th June 2016
Senior Associate Consultant Frances Hendry and Senior Customer Experience Consultant Peter Timmer take a closer look at why audience segmentations usually fail, and how you can make your segmentation actionable so that it can deliver real commercial value.
|31st May 2016
In this article, Customer Experience Consultant Peter Timmer talks through what it means to design with empathy for the customer, and why it produces better products and services for pharma and healthcare.
|25th May 2016
Good user experience (UX) design considers how people feel about products and services and caters for their needs – and space design works exactly the same way. In this article, Consultant Anna Tamasi highlights the key considerations and best practices for spatial design from a user experience design perspective.
|19th May 2016
Blue Latitude Health have worked with four of the eight immunotherapies currently approved by the FDA, so we've pooled our expertise across the different capabilities to give you a clear view on the fourth pillar of care in oncology.
|12th May 2016
In this article, Head of Customer Experience Elisa del Galdo talks us through how market and customer research differ, and in which situations you would use one over the other.